-
Mashup Score: 4Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack - 2 year(s) ago
Background and Purpose: In patients with acute mild-moderate ischemic stroke or high-risk transient ischemic attack, the THALES trial (Acute Stroke or Transient Ischemic Attack Treated With Ticagrelo
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 18
Background: Central retinal artery occlusion (CRAO) causes sudden, irreversible blindness and is a form of acute ischemic stroke. In this study, we sought to determine the proportion of patients in w
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial - 3 year(s) ago
Background and Purpose: The HOPE-3 trial (Heart Outcomes Prevention Evaluation–3) found that antihypertensive therapy combined with a statin reduced first stroke among people at intermediate cardiova
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Tandem Lesions in Anterior Circulation Stroke - 3 year(s) ago
Background and Purpose: Tandem lesions in the anterior circulation account for up to 30% of all large vessel occlusion strokes. The optimal periprocedural approach in these lesions is still a matter
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet
#OpenAccess #CMEavailable Net clinical impact favors #ticagrelor plus #aspirin vs. #aspirin alone in acute mild non-cardioembolic #stroke and high-risk #TIA with ARR of 1% after balancing ischemic and hemorrhagic events #THALES https://t.co/r2whwseufn @ClayJohnstonMD https://t.co/9qSfVvkSFQ